|
Therapeutic Recommendations For The Treatment Of Children With A Retinoblastoma
RECRUITINGSponsored by French Africa Pediatric Oncology Group
Actively Recruiting
SponsorFrench Africa Pediatric Oncology Group
Started2020-11-01
Est. completion2028-12-31
View on ClinicalTrials.gov →
NCT04425434
Summary
As the survival of children with retinoblastoma in high income countries is higher than 95% including the bilateral forms this study hopes to improve the outcome in low income countries in Africa by improving early diagnosis and early implementation of this protocol of therapeutic recommendations for treatment.
Eligibility
Inclusion Criteria: * Unilateral intraocular Retinoblastoma (RB) * Unilateral extraocular intraorbital (RB) * Bilateral intraocular (RB) * bilateral intraocular (RB) on one side and extraocular but intraorbital on the other side. Exclusion Criteria: * Externalized tumor mass * massive extension to optic nerve up to optical channeltumor * intracranial extension leptomeninges * cerebral parenchyma * extension to regional lymph nodes and/or remote metastases. * cerebrospinal fluid involvement. * Trilateral RB * Incapacity to followed the whole treatement.
Conditions2
CancerRetinoblastoma
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorFrench Africa Pediatric Oncology Group
Started2020-11-01
Est. completion2028-12-31
View on ClinicalTrials.gov →
NCT04425434